Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy
Envara Health Named Winner of 2021 PACT Enterprise Awards
Nutrition Company Redefining ‘Food as Medicine’ Recognized for Commitment to Science-Backed Technology in the Life Sciences Industry
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp.
Venatorx Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of VNRX-9945 for the Treatment of Chronic Hepatitis B Virus Infection
Ride Health Raises $10 Million to Scale National Medical Transportation Platform
Company brings real-time visibility to the non-emergency medical transportation industry, improving access to care and social resources for underserved populations
InfraScan Inc. Announces DoD/DHA Product Development Partnership
InfraScan announces product development partnership with DoD
Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors
– Dr. Prendergast is a renowned scientific researcher with over 45 years of association with the Mayo Foundation and over 20 years’ experience as a non-executive director of Eli Lilly
Ossianix Announces Publication of Positive Preclinical Data on Neutralizing SARS-CoV-2 Infection with a Panel of Single Domain Shark VNAR Antibodies
A highly potent panel of VNARs against the SARS-CoV-2 spike protein has been isolated
Neutralization of SARS-CoV-2 was demonstrated in in vitro infectivity assays
In vitro blocking activities were also found against the N501Y and E484K mutants